Banque Cantonale Vaudoise’s Bio-Rad Laboratories Class A BIO Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-375	Closed	-$135K	–	1037
2023 Q3	$135K	Buy	375 +75	+25%	+$28.9K	0.01%	770
2023 Q2	$114K	Hold	300	–	–	0.01%	834
2023 Q1	$144K	Sell	300 -800	-73%	-$374K	0.01%	780
2022 Q4	$462K	Sell	1,100 -1,500	-58%	-$605K	0.02%	463
2022 Q3	$1.08M	Buy	2,600 +100	+4%	+$49.9K	0.06%	308
2022 Q2	$1.24M	Buy	2,500 +700	+39%	+$365K	0.06%	301
2022 Q1	$1.01M	Hold	1,800	–	–	0.04%	387
2021 Q4	$1.36M	Sell	1,800 -500	-22%	-$374K	0.05%	342
2021 Q3	$1.72M	Sell	2,300 -1,700	-43%	-$1.27M	0.07%	262
2021 Q2	$2.58M	Buy	4,000 +1,500	+60%	+$913K	0.11%	185
2021 Q1	$1.43M	Buy	2,500 +1,400	+127%	+$829K	0.07%	279
2020 Q4	$641K	Sell	1,100 -1,700	-61%	-$968K	0.04%	431
2020 Q3	$1.44M	Buy	+2,800	New	+$1.42M	0.09%	194

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Banque Cantonale Vaudoise's BIO Position: Q4 2023 in Review

Banque Cantonale Vaudoise sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 375 shares — an estimated $135K sold.

Banque Cantonale Vaudoise first reported a position in BIO in Q3 2020 and held it in 13 quarters. The position peaked at $2.58M in Q2 2021. 484 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

Banque Cantonale Vaudoise reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
Banque Cantonale Vaudoise sold 375 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $135K.
Banque Cantonale Vaudoise first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and held it in 13 quarters.
Banque Cantonale Vaudoise's Bio-Rad Laboratories Class A position peaked at $2.58M in Q2 2021.
484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on Banque Cantonale Vaudoise's 13F filing for Q4 2023, filed 7 Feb 2024.